Reply to thread

Message: [QUOTE="greenmedinfo, post: 4828"] PMID: Basic Clin Pharmacol Toxicol. 2021 Jan ;128(1):91-102. Epub 2020 Sep 2. PMID: 32780565 Abstract Title: Solidagenone from Solidago chilensis Meyen inhibits skin inflammation in experimental models. Abstract: Solidagenone (SOL) is a labdane-type diterpenoid found in Solidago chilensis, a plant traditionally used to treat skin diseases, kidney pain and ovarian inflammation. In this study, the topical anti-inflammatory activity of SOL was evaluated using in vivo and in silico assays. Croton oil-, arachidonic acid (AA)- and phenol-induced ear oedema mouse models were applied in the in vivo studies. Myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAG) activities and tumour necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and nitric oxide (NO) levels were determined, as well as histopathological analyses were conducted. Interaction profiles between SOL and cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), glucocorticoid receptor, estradiol-17-β-dehydrogenase and prostaglandin-E(2)-9-reductase were established using molecular docking. SOL significantly inhibited croton oil-, AA- and phenol-induced ear oedema (P [URL='https://www.greenmedinfo.com/article/solidagenone-solidago-chilensis-meyen-inhibits-skin-inflammation-experimental-']read more[/URL] [/QUOTE]